Hour24 News
Sophisticated and simple
-
WuXi Biologics Advances with a Scaled CRDMO Platform The CRDMO (Contract Research, Development, and Manufacturing Organization) platform at WuXi Biologics is positioned for sustained high…
-
Overview: A Scaled CRDMO Engine for Sustainable Growth Under the leadership of Dr. Chris Chen, WuXi Biologics has expanded its contract development and manufacturing organization…
-
Overview: A Year of Strategic Investment and Early Impact Tiger BioSciences closed out 2025 with a clear message: deliberate, evidence‑based investment in research accelerates both…
-
Cogent Biosciences Submits New Drug Application to Regulatory Authorities Cogent Biosciences, Inc., a Waltham, Massachusetts and Boulder, Colorado-based biotechnology company focused on precision therapies for…
-
Cogent Biosciences Announces Submission of New Drug Cogent Biosciences, Inc., a biotechnology company focused on precision therapies for genetically defined diseases, announced today that it…
-
Overview: A Strategic Expansion in Vascular Therapy Sunnybrook-based startup Vasomune Therapeutics is broadening its collaboration with pharmaceutical giant AnGes to expand the indications for their…
-
Galux Collaborates with Boehringer Ingelheim to accelerate AI-driven protein design South Korea’s Galux, a biotech startup focused on AI-powered protein therapeutics discovery, has entered a…
-
Overview of Q3 2025 Results Compugen has released its third quarter 2025 results, alongside key data updates from the company’s oncology pipeline. The highlights focus…
-
Overview: New Data Spotlight Regenerative Macrophage Therapy Resolution Therapeutics has announced key updates from its ongoing research into Regenerative Macrophage Therapy (RMT) for cirrhosis, with…
-
Breakthrough in Precision Cancer Therapy: Liver-Sparing in Early Studies Lehi, Utah — CancerVax, Inc., a pre-clinical biotechnology company, announced today that recent in-vitro studies demonstrate…
